Werewolf Therapeutics, Inc. — Director's Dealing 2021

Jun 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Werewolf Therapeutics, Inc. (HOWL)
CIK: 0001785530
Period of Report: 2021-06-14

Reporting Person: RA CAPITAL MANAGEMENT, L.P. (Director, 10% Owner)
Reporting Person: RA Capital Healthcare Fund LP (Director, 10% Owner)
Reporting Person: Kolchinsky Peter (Director, 10% Owner)
Reporting Person: Shah Rajeev M. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	P	306055	$12.75	Acquired	4274638	Indirect
2021-06-15	Common Stock	P	7958	$12.95	Acquired	4282596	Indirect
2021-06-16	Common Stock	P	9285	$13.37	Acquired	4291881	Indirect

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $12.56 to $12.86; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

F2: These securities include 3,830,813 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund") and 443,825 shares held by RA Capital Nexus Fund II, L.P. ("the Nexus Fund II")

F3: This transaction was executed in multiple trades at prices ranging from $12.53 to $13.00; the price reported above reflects the weighted average purchase price.

F4: These securities include 3,838,771 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.

F5: This transaction was executed in multiple trades at prices ranging from $12.92 to $13.50; the price reported above reflects the weighted average purchase price.

F6: These securities include 3,848,056 shares held directly by the Fund and 443,825 shares held by the Nexus Fund II.

F7: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.